A PRODUCT
ANNOUNCEMENT FROM:
Pharmtech logo

ACQUITY UPLC H-Class Bio System


Examine your biopharmaceutical from every angle

Recent advances by Waters in UPLC technologies, fluorescence-based detection, and MS approaches to the characterization of protein glycosylation have led to better resolution, sensitivity, and reliability in glycan analysis in development and quality control.

Learn how Waters is advancing glycan characterization:

  • Gain flexibility in developing glycan methods with the ACQUITY UPLC H-Class Bio System and AutoBlend Plus Technology
    Download application note
  • Reduce complexity in the analysis of glycopeptide glycoforms in a monoclonal antibody tryptic digest by HILIC UPLC with TUV and MS
    Download application note
  • Improve resolution and reproducibility with UPLC column for N-Linked glycans of glycoproteins
    Download application note
  • Attend our on-demand webinar on recent advances in glycan characterization
    Includes guest presenter from NIBRT Dublin-Oxford Glycobiology Group

When combined for use in a biopharmaceutical or pharmaceutical laboratory to monitor glycan profiles, Waters’ solutions for glycan analysis and characterization provide robust, high-resolving, reproducible, and rapid methods that out-perform other analytical technologies.

The business of biopharmaceuticals
By 2014, five of the top five – and 50% of the top 100 – best-selling branded drugs will be proteins. Is your organization positioned to be one of the biopharmaceutical leaders?
How Waters makes a difference

Confidence in your biotherapeutic investment. No compromises in your laboratory.
LC and MS provide the detailed data for structural characterization of complex macromolecules that make up protein-based therapeutics – but ordinary LC and MS instruments won’t get you to insights as effectively or as efficiently.
Learn how Waters technologies are built for biopharmaceutical analyses

Would you like to be contacted by a specialist?
Please contact me

Waters Corporation

Waters, UPLC, and ACQUITY UPLC are registered trademarks of Waters Corporation.
AutoBlend and The Science of What's Possible is a trademark of Waters Corporation.

Follow us on Twitter :: Become a fan on Facebook :: Connect on LinkedIn

Waters Corporation 34 Maple St. Milford, MA 01757 USA
www.waters.com :: Privacy Policy :: Worldwide Offices :: Trademarks


Pharmaceutical Technology is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ 08830.
This is an advertisement sent on behalf of this advertiser.